acute promyelocytic leukemia
AML M3
exact
AML with t(15;17)(q22;q12)
exact
AML with t(15;17)(q22;q12);(PML/RARalpha) and variants
exact
APL
exact
APML
exact
APML - acute promyelocytic leukaemia
exact
APML - acute promyelocytic leukemia
exact
FAB M3
exact
acute myeloblastic leukaemia 3
exact
acute myeloblastic leukemia 3
exact
acute myeloid leukaemia with t(15;17)(q22;q12);(PML/RARalpha) and variants
exact
acute myeloid leukemia with t(15;17)(q22;q12);(PML/RARalpha) and variants
exact
acute promyelocytic leukaemia with PML-rara
exact
acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-rara
exact
acute promyelocytic leukaemia with t(15;17)(q22;q12); PML/rara
exact
acute promyelocytic leukemia
exact
acute promyelocytic leukemia with PML-rara
exact
acute promyelocytic leukemia with t(15;17)(q22;q12); PML-rara
exact
acute promyelocytic leukemia with t(15;17)(q22;q12); PML/rara
exact
leukemia, acute promyelocytic, somatic
exact
promyelocytic leukaemia
exact
promyelocytic leukemia
exact
An aggressive form of acute myeloid leukemia (AML), characterized by arrest of leukocyte differentiation at the promyelocyte stage, due to a specific chromosomal translocation t(15;17) in myeloid cells. APL manifests with easy bruising, hemorrhagic diathesis and fatigue.
MONDO:0011118
bilineal acute myeloid leukemia
excluded_subClassOf
MONDO:0017893
inherited acute myeloid leukemia
is_a